Jeremy Graff
Directeur Technique/Scientifique/R&D chez IMV INC.
Fortune : 5 413 $ au 31/05/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| William Ho | M | 48 | 8 ans | |
| Brittany Davison | F | - | - | |
| Michael P. Bailey | M | 58 | 4 ans | |
| Patrick McCall | M | 41 | 3 ans | |
| Andrew Hall | M | - | 4 ans | |
| Lawrence Lamb | M | 70 | 8 ans | |
| Michael Kalos | M | 62 | 3 ans | |
| Kate Rochlin | M | 43 | 4 ans | |
| Delphine Davan | F | - | 5 ans | |
| Annie Tanguay | F | - | - | |
| Linda Barabe | F | - | - | |
| Saman Maleki | M | - | 2 ans | |
| Travis Whitfill | M | 34 | 6 ans | |
| Markus Warmuth | M | 53 | 6 ans | |
| Kyle Kuvalanka | M | 56 | 3 ans | |
| Emily Fairbairn | F | 62 | 3 ans | |
| Luba Greenwood | F | 45 | 3 ans | |
| Alan Roemer | M | 54 | 4 ans | |
| Peter Brandt | M | 67 | 5 ans | |
| Shabnam Kazmi | F | - | 1 ans | |
| Jennifer Schmitke | M | - | - | |
| Kenneth R. LaMontagne | M | - | 2 ans | |
| Stacey Bilinski | F | - | 2 ans | |
| Urvashi Patel | M | - | 2 ans | |
| Tracy Sherren | F | 58 | - | |
| Trishna Goswami | M | 46 | 3 ans | |
| Ryan Marshall | M | - | 8 ans | |
| Marie-Eve Charrois | F | - | - | |
| Corinne Epperly | M | 46 | 1 ans | |
| Stéphane Fiset | M | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Frederic Ors | M | 50 | 6 ans | |
| Barry A. Labinger | M | 60 |
Biothera Pharmaceutical, Inc.
 Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 3 ans |
| Julia Gregory | F | 71 | 5 ans | |
| James Hall | M | 79 | 11 ans | |
| Shermaine Tilley | M | 72 | 7 ans | |
| Walter Ogier | M | 67 |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 6 ans |
| Pierre Labbé | M | 58 | 5 ans | |
| Joy Bessenger | F | - | 1 ans | |
| Michele Gargano | F | - |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | - |
| Andrew LaFrence | M | 61 |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 1 ans |
| Annalisa Jenkins | M | 58 |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 3 ans |
| Dwight Porter | M | - |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 6 ans |
| Richard Huhn | M | - |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 5 ans |
| Tariq Massad | M | - | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Canada | 23 | 52,27% |
| Etats-Unis | 21 | 47,73% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Jeremy Graff
- Réseau Personnel
